ORTEXORTEX News
Tracking IT? Get live short interest, options flow, and signals on ORTEX.Sign up free →
IT
Earnings PreviewIT

Gartner Shorts Ease, But Street Stays Skeptical Ahead of Q3

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 31 Oct 2026, 04:01

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Gartner fell 0.6% over the past week while its closest peers gained a median 3.1%. That divergence, combined with short interest still running at 9.3% of the free float, frames a print with clear tension between improving sentiment data and a sceptical analyst consensus.

Short interest has pulled back sharply from its October high but remains elevated by any standard. Shorts peaked near 8 million shares in early October before dropping roughly 17% to 6.7 million shares by October 29, a five-week unwind that has been consistent and orderly. The lending market tells a similar story: availability is extremely loose at 1,399%, meaning there are roughly 14 shares available to borrow for every one currently lent out. Cost to borrow, though low at 0.54%, has risen 53% over the past week, a notable move even if the absolute level remains negligible. That combination, heavy short interest pulling back but borrow costs nudging higher, points to some covering activity, but not an outright squeeze.

Options sentiment has shifted notably toward the bullish side. The put/call ratio at 0.66 sits nearly one standard deviation below its 20-day average of 0.71, a reversal from the more defensive readings that persisted through most of September and early October, when the ratio was consistently above 0.78. That shift accompanies an 23% one-month price rally from around $186 to $228.79, a recovery that has left the stock trading well above most of the current analyst price targets. Truist raised its target to $235 on October 20, the only note above where the stock now trades. The broader consensus target is $194, implying material downside from current levels. Wells Fargo, maintaining an Underweight, lifted its target to $175 but is still 23% below the current price. Morgan Stanley's Equal-Weight target sits at $182. The stock has simply run past the Street, and the Q4 print will pressure analysts to either upgrade estimates or defend their cautious stances.

The debate between optimists and pessimists on Gartner is structural rather than cyclical. The bull case rests on a subscription-based model that serves C-suite decision-makers, with contract value retention growing roughly 4% annually before new client additions, over $1 billion in targeted free cash flow, and roughly $2.2 billion in excess cash. Client engagement improved by roughly 140 basis points year on year in the second quarter of 2026, and conference attendance has grown at double-digit rates. The bear case centres on the same business seen through a more hostile macro lens: softer IT spending, tariff-related headwinds, and the risk that Federal contract value declines from government efficiency initiatives could clip the research franchise, which generates about 80% of revenue. Bears also flag disintermediation risk from generative AI tools that could reduce the premium clients place on Gartner's proprietary analysis, a structural worry that the August Q2 print, which drove a 23% one-day move, did not fully answer.

The most notable ownership data point is Baron Capital Group, which reported a position of 7.6 million shares, or 12% of shares outstanding, as of September 30, adding 1.7 million shares in the quarter. That is a concentrated, active-investor bet that goes well beyond a passive index hold. No 13D activist is on the register, and positions here are as-last-disclosed and subject to change without further filing once below the 5% threshold.

Retail attention has climbed sharply in the run-up. Wikipedia view data tracked by the Wikimedia Foundation shows a z-score of 2.2 against the prior 90 days as of October 22, placing it among the more closely watched names in the current market. That is an attention signal, not a fundamental indicator, but it suggests the November 3 print will draw scrutiny well beyond the usual Gartner watcher base.

The earnings release will test whether a 23% one-month price rally, now well above consensus targets, can be justified by contract value growth and margin performance, or whether the Street's structural caution on AI disintermediation and Federal spending headwinds begins to be validated by the actual numbers.

Stocks in this article

See the live data behind this article on ORTEX.

Open IT on ORTEX →

How this article was generated

Generated
31 Oct 2026, 04:11
Data as of
31 Oct 2026, 04:01
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.